POST-COVID

Clinical trials for POST-COVID explained in plain language.

Never miss a new study

Get alerted when new POST-COVID trials appear

Sign up with your email to follow new studies for POST-COVID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Fluvoxamine tested as treatment for long COVID fatigue in new trial

Symptom relief Not yet recruiting

This study tests whether fluvoxamine, a type of antidepressant, can reduce severe fatigue and other symptoms in people with long COVID. About 160 adults aged 18 to 70 who have been severely fatigued for at least 3 months after a COVID-19 infection will receive either fluvoxamine …

Matched conditions: POST-COVID

Phase: PHASE3 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Symptom relief

Last updated May 17, 2026 11:55 UTC

POST-COVID

Get alerted when new POST-COVID trials appear

Fluvoxamine tested as treatment for long COVID fatigue in new trial